First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
Titel:
First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
Auteur:
Tocoian, A Buchan, P Kirby, H Soranson, J Zamacona, M Walley, R Mitchell, N Esfandiari, E Wagner, F Oliver, R